Recombinant Pseudoalteromonas haloplanktis UPF0060 membrane protein PSHAa1175 (PSHAa1175)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Pseudoalteromonas haloplanktis UPF0060 Membrane Protein PSHAa1175

The recombinant Pseudoalteromonas haloplanktis UPF0060 membrane protein PSHAa1175, hereafter referred to as PSHAa1175, is a protein derived from the bacterium Pseudoalteromonas haloplanktis. This protein is expressed in Escherichia coli and is fused with an N-terminal His tag for easier purification and identification. PSHAa1175 is a full-length protein consisting of 107 amino acids and is classified under the UPF0060 family of membrane proteins .

2.1. Protein Structure and Function

PSHAa1175 is a membrane protein, which suggests its involvement in various cellular processes such as signaling, transport, or structural support within the cell membrane. The specific function of PSHAa1175 in Pseudoalteromonas haloplanktis is not extensively documented, but its classification as a UPF0060 membrane protein indicates potential roles in membrane-related activities.

2.2. Expression and Purification

The recombinant form of PSHAa1175 is expressed in E. coli, which is a common host for recombinant protein production due to its well-understood genetics and efficient expression systems. The protein is purified to a high degree (>90%) as determined by SDS-PAGE, indicating its suitability for further biochemical studies .

Table 1: Characteristics of Recombinant PSHAa1175

CharacteristicDescription
Protein LengthFull Length (1-107 amino acids)
Expression HostEscherichia coli
TagN-terminal His tag
Purity>90% by SDS-PAGE
Storage Conditions-20°C or -80°C
ReconstitutionDeionized sterile water, 0.1-1.0 mg/mL

Table 2: Comparison of Protein Production Systems

Production SystemAdvantagesDisadvantages
Planktonic E. coliFast production, well-established protocolsMay produce insoluble or proteolyzed proteins
Biofilm Pseudoalteromonas haloplanktisHigher quality products, lower carbon source requirementsSlower production rate, less established protocols

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. To ensure a specific tag, please indicate your preference; we will prioritize its development.
Synonyms
PSHAa1175; UPF0060 membrane protein PSHAa1175
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-107
Protein Length
full length protein
Species
Pseudoalteromonas haloplanktis (strain TAC 125)
Target Names
PSHAa1175
Target Protein Sequence
MKIFGLFLITALAEIIGCYLPYLWLREGKSVWLLVPAALSLAIFAWLLSLHPAAAGRVYA AYGGVYIFMAILWLWAVDGIRPTTWDLVGSGVALVGMAIIMFAPRSV
Uniprot No.

Target Background

Database Links
Protein Families
UPF0060 family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is the structural classification of PSHAa1175 membrane protein?

PSHAa1175 belongs to the UPF0060 family of membrane proteins found in Pseudoalteromonas haloplanktis. Most transmembrane proteins like PSHAa1175 typically traverse the lipid bilayer with their polypeptide chain forming regular α-helical structures, which maximizes hydrogen bonding between peptide bonds in the hydrophobic environment of the membrane . When investigating PSHAa1175, researchers should employ structural prediction methods such as hydropathy analysis to identify potential membrane-spanning regions, followed by experimental validation using techniques like circular dichroism or X-ray crystallography to confirm secondary structure elements.

How does the cellular location of PSHAa1175 affect experimental approaches?

As a membrane protein, PSHAa1175 presents unique experimental challenges compared to soluble proteins. The protein's integration within the lipid bilayer necessitates specialized extraction and purification protocols. Researchers should consider that membrane proteins can be arranged in different orientations – transmembrane proteins that cross the bilayer once or multiple times, or peripheral proteins that associate with membrane surfaces . The specific membrane localization of PSHAa1175 will determine appropriate detergent selection for solubilization, choice of expression systems, and purification strategies to maintain native structure and function.

What expression systems are most suitable for recombinant PSHAa1175 production?

For recombinant production of PSHAa1175, researchers should consider that membrane proteins often require specialized expression systems. Based on the cold-adapted nature of Pseudoalteromonas haloplanktis, low-temperature expression hosts may improve proper folding and functional yield. A methodological approach would involve:

  • Evaluating multiple expression systems (E. coli, yeast, insect cells, mammalian cells)

  • Testing various promoters and fusion tags to enhance solubility

  • Optimizing culture conditions (temperature, induction timing, media composition)

  • Comparing protein yield and functionality across systems

The optimal expression system should balance high yield with proper folding and post-translational modifications required for functional studies.

How can researchers distinguish between different conformational states of PSHAa1175?

Membrane proteins like PSHAa1175 typically exist in multiple conformational states that may be functionally relevant. To distinguish between these states, researchers should employ a combination of:

  • Biophysical techniques: Circular dichroism (CD) spectroscopy, fluorescence spectroscopy, and nuclear magnetic resonance (NMR) can detect conformational changes under different conditions.

  • Functional assays: Develop assays specific to the hypothesized function of PSHAa1175 to correlate structural changes with activity.

  • Cross-linking studies: Chemical cross-linking coupled with mass spectrometry can capture transient interactions and conformational states.

  • Computational modeling: Molecular dynamics simulations can predict conformational transitions and stable states based on primary sequence data.

Different conformational states should be characterized under various conditions (pH, temperature, ligand binding) to establish a comprehensive conformational landscape relevant to the protein's function.

What approaches can resolve contradictory functional data for PSHAa1175?

When faced with contradictory functional data for PSHAa1175, researchers should implement a systematic troubleshooting strategy:

  • Standardize experimental conditions across laboratories, including protein preparation methods, buffer compositions, and assay protocols.

  • Evaluate potential sources of variability:

    • Protein purity and integrity (verify by SDS-PAGE, mass spectrometry)

    • Lipid environment effects (test different lipid compositions)

    • Post-translational modifications (identify using mass spectrometry)

    • Presence of interacting partners (perform pull-down assays)

  • Conduct blind replications in multiple laboratories using identical protocols.

  • Implement orthogonal assays that measure the same function through different mechanisms to validate findings.

Resolution of contradictory data often requires systematic variance analysis to identify specific experimental factors contributing to discrepancies.

How should researchers design experiments to study PSHAa1175 interaction with the membrane environment?

For studying PSHAa1175 interactions with the membrane environment, researchers should implement a multi-technique approach:

  • Reconstitution studies: Incorporate purified PSHAa1175 into artificial membrane systems (liposomes, nanodiscs) with varying lipid compositions to assess how lipid environment affects protein structure and function.

  • Fluorescence techniques: Utilize FRET (Förster Resonance Energy Transfer) or fluorescence anisotropy to measure protein-lipid interactions and protein dynamics within membranes.

  • Molecular dynamics simulations: Simulate PSHAa1175 behavior in different lipid environments to predict optimal conditions for functional studies.

  • Site-directed spin labeling: Introduce spin labels at specific sites to probe accessibility and conformational changes using electron paramagnetic resonance (EPR) spectroscopy.

The experimental design should account for the natural membrane environment of Pseudoalteromonas haloplanktis, which may have unique lipid compositions adapted to cold marine conditions.

What is the optimal experimental design for studying temperature-dependent effects on PSHAa1175 function?

Given that Pseudoalteromonas haloplanktis is a cold-adapted bacterium, temperature-dependent studies of PSHAa1175 are particularly relevant. An optimal experimental design would include:

  • Controlled temperature gradient experiments:

    • Systematically test protein stability and function across 0-37°C range

    • Monitor structural changes using CD spectroscopy at each temperature point

    • Correlate structural changes with functional assays

  • Kinetic analyses at different temperatures:

    • Measure reaction rates or binding kinetics at 4-5 different temperatures

    • Create Arrhenius plots to determine activation energies

    • Compare with mesophilic homologs to identify cold-adaptation features

  • Staggered experimental design:

    • Implement a stepped wedge design as described in optimal experimental design literature

    • This approach allows for systematic introduction of temperature variables while controlling for time-dependent effects

The experimental design should include appropriate controls and statistical power calculations to detect temperature-dependent effects with confidence.

What purification strategies yield the highest functional recovery of recombinant PSHAa1175?

Purification of functional membrane proteins like PSHAa1175 requires specialized approaches:

Purification StepMethod OptionsConsiderations for PSHAa1175
ExtractionDetergent solubilization, Amphipol extractionMild detergents (DDM, LMNG) often preserve function better than harsh detergents (SDS)
Initial captureIMAC, Affinity chromatographyHis-tag or other fusion tags should be strategically placed to avoid functional regions
Intermediate purificationIon exchange, Size exclusionBuffer composition crucial; consider including stabilizing ligands
Final polishingSize exclusion, Reverse phaseAssess protein homogeneity and detergent content
Quality controlSDS-PAGE, Mass spectrometry, Activity assaysVerify purity, integrity, and functional state

For cold-adapted proteins like PSHAa1175, maintaining lower temperatures throughout purification may improve recovery of functional protein. The purification strategy should be validated by assessing both protein purity and retention of native function.

How can researchers effectively design mutagenesis studies to elucidate structure-function relationships in PSHAa1175?

A comprehensive mutagenesis strategy for PSHAa1175 should include:

  • Sequence-based targeting:

    • Perform multiple sequence alignment with homologous proteins

    • Identify conserved residues as primary targets

    • Consider evolutionary conservation scores to prioritize mutations

  • Structure-based targeting:

    • If structural data is available, focus on residues in potential active sites

    • Target residues at predicted membrane interfaces

    • Examine predicted transmembrane regions and loops

  • Systematic approach options:

    • Alanine scanning: Replace continuous segments with alanine to identify functional regions

    • Conservative vs. non-conservative mutations: Compare effects of subtle vs. dramatic amino acid changes

    • Domain swapping: Exchange domains with homologous proteins to identify functional modules

  • Validation:

    • Express and purify each mutant under identical conditions

    • Perform parallel functional assays to quantitatively compare activities

    • Conduct structural analyses to confirm mutagenesis didn't disrupt global folding

This methodology ensures that mutagenesis studies yield interpretable data connecting specific residues to protein function.

How do post-translational modifications affect PSHAa1175 function and localization?

For investigating post-translational modifications (PTMs) of PSHAa1175, researchers should implement this methodological approach:

  • Identification of potential PTMs:

    • Perform comprehensive mass spectrometry analysis of native and recombinant PSHAa1175

    • Compare PTM profiles across different expression systems

    • Use predictive algorithms to identify potential modification sites

  • Functional impact assessment:

    • Generate site-directed mutants at PTM sites (mimicking or preventing modification)

    • Compare functional parameters between wild-type and mutant proteins

    • Correlate PTM presence with subcellular localization using fluorescent tagging

  • Temporal dynamics:

    • Analyze modification patterns under different growth conditions

    • Track modifications through protein maturation and trafficking

    • Identify enzymes responsible for each modification using inhibitor studies or knockdown approaches

The membrane localization of PSHAa1175 may involve specific PTMs, similar to GPI anchors or lipid modifications seen in other membrane proteins , which could be critical for proper membrane integration and function.

What computational approaches best predict ligand binding sites in PSHAa1175?

Computational prediction of ligand binding sites in membrane proteins like PSHAa1175 requires specialized approaches:

  • Homology modeling:

    • Generate structural models based on homologous proteins of known structure

    • Validate models using energy minimization and Ramachandran plots

    • Compare multiple models from different templates for consensus regions

  • Binding site prediction algorithms:

    • Apply cavity detection algorithms (POCASA, FPocket)

    • Use evolutionary conservation mapping (ConSurf)

    • Implement molecular docking simulations with potential ligands

  • Molecular dynamics:

    • Perform long-timescale simulations to identify stable binding pockets

    • Analyze water and ion access to potential binding sites

    • Calculate binding energies for putative ligands

  • Validation:

    • Design experiments to test predictions (mutagenesis, binding assays)

    • Refine models based on experimental feedback

    • Implement multiple computational approaches and look for consensus predictions

Computational predictions should be treated as hypotheses requiring experimental validation, particularly for membrane proteins where structural information is often limited.

How can researchers integrate PSHAa1175 functional data into broader cellular pathway models?

Integrating membrane protein function into systems biology frameworks requires specialized methodological approaches:

  • Interactome mapping:

    • Perform pull-down assays coupled with mass spectrometry

    • Use bacterial two-hybrid or membrane-specific yeast two-hybrid systems

    • Validate interactions with co-immunoprecipitation or FRET-based approaches

  • Network analysis:

    • Incorporate interaction data into protein-protein interaction networks

    • Identify functional clusters and pathway associations

    • Compare network positions of homologous proteins across species

  • Multi-omics integration:

    • Correlate PSHAa1175 expression levels with transcriptomic changes

    • Analyze metabolomic shifts in knockout or overexpression conditions

    • Map changes to known metabolic or signaling pathways

  • Mathematical modeling:

    • Develop kinetic models incorporating PSHAa1175 function

    • Use flux balance analysis to predict systemic effects of PSHAa1175 perturbation

    • Simulate condition-specific behaviors (temperature shifts, nutrient limitation)

This systems-level approach provides context for understanding PSHAa1175's role beyond its immediate function, potentially revealing unexpected relationships within the cellular network.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.